Hims & Hers Health Revenue 2020-2023 | HIMS
Hims & Hers Health Annual Revenue (Millions of US $) |
|
---|---|
2023 | $872 |
2022 | $527 |
2021 | $272 |
2020 | $149 |
2019 | $83 |
2018 | $ |
Hims & Hers Health Quarterly Revenue (Millions of US $) |
|
---|---|
2023-12-31 | $247 |
2023-09-30 | $227 |
2023-06-30 | $208 |
2023-03-31 | $191 |
2022-12-31 | $167 |
2022-09-30 | $145 |
2022-06-30 | $114 |
2022-03-31 | $101 |
2021-12-31 | $85 |
2021-09-30 | $74 |
2021-06-30 | $61 |
2021-03-31 | $52 |
2020-12-31 | $41 |
2020-09-30 | $41 |
2020-06-30 | $36 |
2020-03-31 | $30 |
2019-12-31 | |
2019-09-30 | |
2019-06-30 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.678B | $0.872B |
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
Axonics (AXNX) | United States | $3.401B | 0.00 |
10x Genomics (TXG) | United States | $3.288B | 0.00 |
Enovis (ENOV) | United States | $3.030B | 23.02 |
Azenta (AZTA) | United States | $2.910B | 237.18 |
Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
Privia Health (PRVA) | United States | $2.167B | 96.11 |
Schrodinger (SDGR) | United States | $1.733B | 0.00 |
Omnicell (OMCL) | United States | $1.279B | 31.30 |
Phreesia (PHR) | United States | $1.162B | 0.00 |
Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
Standard BioTools (LAB) | United States | $0.708B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
Talkspace (TALK) | United States | $0.527B | 0.00 |
Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
Pulmonx (LUNG) | United States | $0.281B | 0.00 |
Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
American Well (AMWL) | United States | $0.153B | 0.00 |
MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
Augmedix (AUGX) | United States | $0.139B | 0.00 |
Outset Medical (OM) | United States | $0.124B | 0.00 |
TruBridge (TBRG) | United States | $0.118B | 5.03 |
111 (YI) | China | $0.086B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
Movano (MOVE) | United States | $0.026B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
Akili (AKLI) | United States | $0.019B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
CareCloud (CCLD) | United States | $0.017B | 0.00 |
ETAO (ETAO) | United States | $0.015B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |